HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cloyd, G. M. Articles by Akins, C. W. Search for Related Content PubMed PubMed Citation Articles by Cloyd, G. M. Articles by Akins, C. W.

The Journal of Thoracic and Cardiovascular Surgery, Vol 94, 535-538, Copyright © 1987 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting

GM Cloyd, MN D'Ambra and CW Akins
Department of Anesthesia, Massachusetts General Hospital, Boston 02114.

Patients are at risk for a diminished anticoagulant response to heparin during coronary artery bypass graft operations. To answer the question of whether preoperative heparin therapy and intra-aortic balloon counterpulsation are associated with a diminished response in the period before cardiopulmonary bypass, we observed prospectively the baseline and postheparinization activated clotting times in 76 patients undergoing elective coronary artery bypass graft procedures. They included 42 patients who had received preoperative heparin therapy (26 had intra-aortic balloon pumps and 16 did not). Thirty-four comparison patients (controls) were matched for age, sex, race, and heparin lot. Patients receiving preoperative heparin therapy, either with or without intra-aortic balloon pumps, had significantly lower activated clotting times than patients in the control group after a 300 IU/kg dose of porcine intestinal heparin. Total preoperative heparin dose, days of preoperative heparin therapy, and baseline activated clotting times were not predictive of heparin resistance. In conclusion, patients receiving preoperative heparin therapy (with or without intra-aortic balloon pumps) are at increased risk for inadequate heparinization before cardiopulmonary bypass.

This article has been cited by other articles:

				B. D. Spiess Treating heparin resistance with antithrombin or fresh frozen plasma. Ann. Thorac. Surg., June 1, 2008; 85(6): 2153 - 2160. [Abstract] [Full Text] [PDF]

				S. Bar-Yosef, H. B. Cozart, B. Phillips-Bute, J. P. Mathew, and H. P. Grocott Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery: [L'heparine de bas poids moleculaire en preoperatoire reduit la reponse a l'heparine pendant la chirurgie cardiaque] Can J Anesth, February 1, 2007; 54(2): 107 - 113. [Abstract] [Full Text] [PDF]

				T. Chan, N. C. Hwang, and C. H. Lim A statistical analysis of factors predisposing patients to heparin resistance Perfusion, March 1, 2006; 21(2): 99 - 103. [Abstract] [PDF]

				M. Ranucci, G. Isgro, A. Cazzaniga, A. Ditta, A. Boncilli, M. Cotza, G. Carboni, and S. Brozzi Different patterns of heparin resistance: therapeutic implications Perfusion, May 1, 2002; 17(3): 199 - 204. [Abstract] [PDF]

				S. C. Nicholson, D. M. Keeling, M. E. Sinclair, and R. D. Evans Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass Br. J. Anaesth., December 1, 2001; 87(6): 844 - 847. [Abstract] [Full Text] [PDF]

				M. R. Williams, A. B. D'Ambra, J. R. Beck, T. B. Spanier, D. L.S. Morales, D. N. Helman, and M. C. Oz A randomized trial of antithrombin concentrate for treatment of heparin resistance Ann. Thorac. Surg., September 1, 2000; 70(3): 873 - 877. [Abstract] [Full Text] [PDF]

				M. Ranucci, G. Isgro, A. Cazzaniga, G. Soro, L. Menicanti, and A. Frigiola Predictors for heparin resistance in patients undergoing coronary artery bypass grafting Perfusion, December 1, 1999; 14(6): 437 - 442. [Abstract] [PDF]

				M Ranucci, A Cazzaniga, G Isgro, A Ditta, A Boncilli, M Cotza, and S Brozzi Gabexate mesilate and antithrombin III for intraoperative anticoagulation in heparin pretreated patients Perfusion, September 1, 1999; 14(5): 357 - 362. [Abstract] [PDF]

				A. S. Weisinger and J. H. Levy Current Hematologic Issues in Cardiac Surgery and Cardiopulmonary Bypass Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1998; 2(4): 259 - 271. [Abstract] [PDF]

				T. Edmunds, S. M. Van Patten, J. Pollock, E. Hanson, R. Bernasconi, E. Higgins, P. Manavalan, C. Ziomek, H. Meade, J. M. McPherson, et al. Transgenically Produced Human Antithrombin: Structural and Functional Comparison to Human Plasma-Derived Antithrombin Blood, June 15, 1998; 91(12): 4561 - 4571. [Abstract] [Full Text] [PDF]

				D. R. Jobes, G. L. Aitken, and G. W. Shaffer Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion patients undergoing primary cardiac operations J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 36 - 45. [Abstract] [Full Text]

				C. Aren Review article : Heparin and protamine during cardiac surgery Perfusion, July 1, 1989; 4(3): 171 - 181. [PDF]